Shopping cart
Your cart empty!
New blood test to 'revolutionise' NHS cancer treatment
A new ultra-sensitive blood test which can detect tiny fragments of tumour DNA could be "revolutionary" for NHS patients.
Thousands of patients will be offered liquid biopsies, which can help fast-track lung cancer patients to receive targeted treatments. Tissue biopsies are used to confirm a diagnosis of lung cancer and samples can be sent for genomic testing.
But liquid biopsies allow for results much faster, and can show patients if they have mutations. Rebeca Proctor, 41, was treated a suspected chest infection last December.
After she began coughing up blood, she was diagnosed with stage four cancer - which she called a "punch to the gut". "I was scared - I just thought about my children, and if I would get to see my little girl start nursery, and how I would explain my diagnosis to my children - it was just heartbreaking to think about," the mother of four from Carlisle said.
A liquid biopsy showed she had an ALK genetic mutation of her non-small-cell lung cancer. A tissue biopsy took ten days longer to confirm the same result, but in the meantime she could begin a targeted treatment.
New medication has "given me my life back.
Amir Nisi
Creative and experienced content writer with 6+ years of experience lazy to create unique content strategy for News5 to turn website visitors into customers.
Related to this topic:
AI and Marketing: Unlocking Customer Insights
Feb 22, 2024
